Text Size

Clinical Application of Breast Blood-oxygen Functional Imaging Technology

This study is not yet open for participant recruitment.
Verified May 2012 by Tianjin Medical University Cancer Institute and Hospital
Sponsor:
Information provided by (Responsible Party):
Tianjin Medical University Cancer Institute and Hospital
ClinicalTrials.gov Identifier:
NCT01678170
First received: August 30, 2012
Last updated: August 31, 2012
Last verified: May 2012
History of Changes
  Purpose

This trial is going to evaluate the value of blood-oxygen functional imaging technology in the diagnosis of breast diseases.


Condition
Breast Diseases

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Clinical Application of Breast Blood-oxygen Functional Imaging Technology

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Tianjin Medical University Cancer Institute and Hospital:

Estimated Enrollment: 200
Study Start Date: September 2012
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Female with breast lump, received breast ultrasound and mammography

Criteria

Inclusion Criteria:

  • female older than 18 years breast lump received breast ultrasound and mammography

Exclusion Criteria:

  • After core-needle biopsy or resection After neoadjuvant chemotherapy, radiotherapy or endocrine therapy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01678170

Contacts
Contact: Peifang Liu, M.D. +86-22-23524536 cjr.liupeifang@vip.163.com

Locations
China, Tianjin
Department of Breast Imaging, Tianjin Medical University Cancer Hospital
Tianjin, Tianjin, China, 300060
Sponsors and Collaborators
Tianjin Medical University Cancer Institute and Hospital
Investigators
Principal Investigator: Peifang Liu, M.D. Department of Breast Imaging, Tianjin Medical University Cancer Hospital
  More Information

No publications provided

Responsible Party: Tianjin Medical University Cancer Institute and Hospital
ClinicalTrials.gov Identifier: NCT01678170     History of Changes
Other Study ID Numbers: CIH-LPF-201205001
Study First Received: August 30, 2012
Last Updated: August 31, 2012
Health Authority: China: Food and Drug Administration

Keywords provided by Tianjin Medical University Cancer Institute and Hospital:
blood-oxygen functional imaging technology
diagnosis

Additional relevant MeSH terms:
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on May 16, 2013